Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia (Q39387590)

11 September 2017

Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia (English)

1 reference

11 September 2017

0 references

Sensen Lin

1

1 reference

11 September 2017

Shuying Wan

2

1 reference

11 September 2017

Li Sun

3

1 reference

11 September 2017

Jialiang Hu

4

1 reference

11 September 2017

Dongdong Fang

5

1 reference

11 September 2017

Renping Zhao

6

1 reference

11 September 2017

Shengtao Yuan

7

1 reference

11 September 2017

Luyong Zhang

8

1 reference

11 September 2017

language of work or name

1 reference

12 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

103

1 reference

11 September 2017

5

1 reference

11 September 2017

904-912

1 reference

The biology of chemokines and their receptors

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

The chemokine and chemokine receptor superfamilies and their molecular evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Expression of CCL5 (RANTES) and CCR5 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

HIF-1 and tumor progression: pathophysiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Tumor hypoxia: a target for selective cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Hypoxia and hypoxia-inducible factors: master regulators of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Chemokines in gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Tumour immunity: effector response to tumour and role of the microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Divergent effects of hypoxia on dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2012.02259.X

Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22380870

12 December 2020

inferred from PubMed ID database lookup

Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22380870

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1349-7006.2012.02259.X

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ip7kdtj66rdo7cvjjavcctwjbu

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ip7kdtj66rdo7cvjjavcctwjbu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ip7kdtj66rdo7cvjjavcctwjbu

30 July 2022

mapped directly with Wikidata item

0 references

1 reference

https://api.fatcat.wiki/v0/release/ip7kdtj66rdo7cvjjavcctwjbu

30 July 2022